COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Results of FORTITUDE-ALS, a Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS, Presented at American Academy of Neurology Annual Meeting
05/05/2019
Trial Did Not Meet Statistical Significance for Primary Efficacy Analysis Patients on All Doses of Reldesemtiv Declined Less Than Patients on Placebo for SVC and ALSFRS-R, With Clinically Meaningful Differences Emerging [...]
AveXis presented robust data at AAN demonstrating efficacy of Zolgensma® in broad spectrum of spinal muscular atrophy (SMA) patients
05/05/2019
Interim data reported for the first time from STRONG in SMA Type 2 showed rapid motor function gains and milestone achievements with intrathecal Zolgensma (onasemnogene abeparvovec-xioi; AVXS-101) New interim data from [...]
Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting
05/05/2019
Results Confirm the Posterior Trajectory as an Additional Surgical Delivery Route for VY-AADC in Patients with Parkinson’s Disease T reatment with VY-AADC Improved Good ON Time (ON Time Without Troublesome Dyskinesia) [...]
Emerald Health Therapeutics annonce les résultats financiers du quatrième trimestre et de l’exercice 2018; faits saillants entourant la croissance des ventes au T1 2019
04/05/2019
Les ventes d’Emerald au T4 2018 et au T1 2019 ont fortement progressé par rapport à la même période l’an dernier et par rapport au trimestre précédent; la coentreprise Pure Sunfarms devrait enregistrer au premier [...]
RavenQuest Awarded its First Cannabis Sales License from Health Canada
03/05/2019
VANCOUVER, British Columbia, May 03, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/05/2019
BURLINGTON, Mass., May 03, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to two new employees consisting of an aggregate of 7,600 stock options and 1,250 [...]
Align Technology to Speak at Upcoming Financial Conferences
03/05/2019
SAN JOSE, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will [...]
Les vendeurs de Verdélite recevront des actions d’Emerald au lieu d’un paiement comptant
03/05/2019
Vancouver, Colombie-Britannique, 03 mai 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (« Emerald » ou la « Société ») a annoncé aujourd’hui que les vendeurs (les « vendeurs ») de Verdélite [...]
Guardant Health to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
03/05/2019
REDWOOD CITY, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results
03/05/2019
MENLO PARK, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached. During the first [...]
Align Provides Update on Patent Infringement Case Against 3Shape
03/05/2019
Administrative Law Judge (ALJ) Finds 19 of 20 Asserted Align Patent Claims Valid ALJ Initial Determination Finds No Section 337 Violation Based on Her Construction of Relevant Claim Terms ALJ Ruling Not Final and Align [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2019
03/05/2019
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2019
03/05/2019
Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Synergy CHC Corp. Announces First Quarter 2019 Results
03/05/2019
Westbrook, Maine, May 03, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended March 31, 2019 [...]
Motif Bio meeting with U.S. FDA held as planned
03/05/2019
NEW YORK, May 03, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, confirms that the Company met with the U.S. Food [...]
SRS Health to Showcase Latest Enhancements and Integrations at the American Association of Orthopaedic Executives in Nashville, TN
03/05/2019
An ePrescribing module, patient portal and transcription application to be highlighted at the upcoming annual meeting MONTVALE, N.J., May 03, 2019 (GLOBE NEWSWIRE) -- SRS Health, a Nextech Company and leading innovator [...]
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
03/05/2019
LONDON, May 03, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH, NASDAQ:MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announces that the Trustee of the Mereo [...]
ORION CORPORATION: ACQUISITION OF OWN SHARES 03.05.2019
03/05/2019
Orion Corporation NOTIFICATION 03.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 03.05.2019 Date 03.05.2019 Exchange transaction Buy Share class ORNBV Amount 40,000 Average price/share 29.6834 EUR Highest [...]
Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma
03/05/2019
Preliminary data show rapid, visible response to Oraxol monotherapy in the first seven subjects, including three complete responses BUFFALO, N.Y., May 03, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global [...]

Pages